Abstract: The present invention provides a pharmaceutical composition containing a quinoline derivative or a salt thereof. Specifically, the invention provides a pharmaceutical composition containing (R,E)-N-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-3-(1-methylpyrrolidin-2-yl)-propeneamide or a pharmaceutically acceptable salt thereof, a cross-linked polyvinylpyrrolidone, and at least one pharmaceutically acceptable excipient. The pharmaceutical composition has a property of rapid dissolution.

Abstract: A portable gradient control plate providing protection against touch potentials for electrical workers that can be carried and set-up at workplace conveniently. The gradient control plate has a perforated top plate for stability and extra foot grip minimizing slip hazards. It is supported by aluminum members thus elevating the foot above grade. The gradient control plate can be folded through hinges and equipped with a handle introducing portability into the apparatus. Each aluminum plate is secured by a locking mechanism and bonded by a braided copper wire to ensure equipotential between plates. Aluminum rods for attaching hotline clamps will be placed on each side of the gradient control plate for electrical connection to the power source.

Abstract: A portable gradient control plate providing protection against touch potentials for electrical workers that can be carried and set-up at workplace conveniently. The gradient control plate has a perforated top plate for stability and extra foot grip minimizing slip hazards. It is supported by aluminum members thus elevating the foot above grade. The gradient control plate can be folded through hinges and equipped with a handle introducing portability into the apparatus. Each aluminum plate is secured by a locking mechanism and bonded by a braided copper wire to ensure equipotential between plates. Aluminum rods for attaching hotline clamps will be placed on each side of the gradient control plate for electrical connection to the power source.

Abstract: The present invention provides a method for preparing a pharmaceutical composition containing a pyrrolo-fused six-membered heterocyclic compound or a pharmaceutically acceptable salt thereof. Specifically, the invention provides a preparation method of a pharmaceutical composition, the method containing: mixing 5-(2-diethylamino-ethyl)-2-(5-fluoro-2-oxo-1,2-dihydro-indol-3-ylidene-methyl)-3-methyl-1,5,6,7-tetrahydro-pyrrolo[3,2-c]pyridin-4-one or a pharmaceutically acceptable salt thereof with at least one filler, and then granulating the mixture. The pharmaceutical composition of the invention features a rapid dissolution and good stability.

Abstract: The present invention provides a pharmaceutical composition containing a pyrrolo-fused six-membered heterocyclic compound or a pharmaceutically acceptable salt of the compound. Specifically, the invention provides a pharmaceutical composition containing 5-(2-diethylamino-ethyl)-2-(5-fluoro-2-oxo-1,2-dihydro-indol-3-ylidene-methyl)-3-methyl-1,5,6,7-tetrahydro-pyrrolo[3,2-c]pyridin-4-one or a pharmaceutically acceptable salt thereof, and at least one water soluble filler. The pharmaceutical composition of the invention features a rapid dissolution and good stability.

Abstract: The present invention provides a method for preparing a pharmaceutical composition containing a quinoline derivative or a salt thereof. Specifically, the invention provides a method for preparing a pharmaceutical composition containing (R,E)-N-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-3-(1-methylpyrrolidin-2-yl)-propeneamide or a pharmaceutically acceptable salt thereof. The method uses a wetting agent containing at least one organic solvent for a wet granulation in a preparation process of the pharmaceutical composition. The pharmaceutical composition prepared using the method has a uniform distribution of grain sizes during the preparation process and a property of rapid and uniform dissolution.

Abstract: The present disclosure discloses methods, systems and modules for adjusting an interpupillary distance of a head-mounted 3D display. The method comprising: receiving a signal to start the head-mounted 3D display, after receiving the signal, scanning an interpupillary distance of a user wearing the head-mounted 3D display; setting centers of left and right eye images of a display screen based on the interpupillary distance of the user, wherein the centers of the left and right eye images are symmetrical about a physical midline of the display screen; and playing the same left and right eye guiding images by taking the centers of the left and right eye images as their centers, respectively, on the display screen to guide the user to adjust positions of left and right eye lenses. A head-mounted 3D display adopting the technical solution of this invention has an interpupillary distance adjustment function, making it suitable for different users.

Abstract: The present disclosure discloses methods, systems and modules for adjusting an interpupillary distance of a head-mounted 3D display. The method comprising: receiving a signal to start the head-mounted 3D display, after receiving the signal, scanning an interpupillary distance of a user wearing the head-mounted 3D display; setting centers of left and right eye images of a display screen based on the interpupillary distance of the user, wherein the centers of the left and right eye images are symmetrical about a physical midline of the display screen; and playing the same left and right eye guiding images by taking the centers of the left and right eye images as their centers, respectively, on the display screen to guide the user to adjust positions of left and right eye lenses. A head-mounted 3D display adopting the technical solution of this invention has an interpupillary distance adjustment function, making it suitable for different users.